Days Set Up
Monday - Friday
Analytic Time

Tier 1 (DIGP1)(rqPCR): 7 days; Tier 2 (DIGP2)(microarray): 28 days.

MiChart Code
DiGeorge Panel: Reflex to all Tiers
Soft Order Code
DIGP1

Test Updated:

Synonyms

Chromosomal Microarray (CMA)
DIGP2
Velocardiofacial Syndrome (VCFS)
CATCH 22
SNPM1
DIGP1
rqPCR for 22q11.2 deletion

Looking to order a test?

We’ve provided helpful links to make ordering easy.

Find a Requisition

All specimens should be accompanied by a requisition.

Submitting Specimens

Learn about how to properly label and where to ship specimens.

Order Kits and Supplies

MLabs provides all the supplies necessary for the collection of specimens.

Test FAQ

Visit our provider FAQ and learn about common questions to ordering tests.

Test Overview

Test Methodology

Relative-quantitative PCR uses TaqMan probe and primers to amplify and detect a targeted DNA segment so that the copy number of the target can be calculated in comparison to a calibrator DNA sample. The relative copy number of the target region is calculated based on a calibrator copy number of "two" for most genomic regions.
The Illumina CytoSNP-850K Chromosomal Microarray (CMA) may not detect low-level mosaicism, and cannot detect chromosomal aberrations that do not result in net gains or losses of genomic material, such as balanced chromosomal rearrangements (balanced translocations, balanced insertions, and inversions), rearrangements in repeat sequences (short arms of acrocentric chromosomes and heterochromatic regions), point mutations, indels, and epigenetic alterations. CMA will not detect genomic imbalances in regions that are not represented on the array.

Test Usage

Confirmation of a clinical or a suspected diagnosis of DiGeorge syndrome in a patient. Tier 1 of this panel includes rqPCR using multiple TaqMan probes within the most common region deleted in the 22q11.2 deletion. This panel test will automatically reflex to Tier 2 (Chromosomal Microarray, CMA) when rqPCR detects a normal genomic copy number or if only one the TaqMan probes detects an abnormal genomic copy within the 22q11.2 region. However, if multiple TaqMan probes detect an abnormal copy number, then a reflexive CMA will not be performed. In this case, a physician can order an add-on CMA test if desired.

Reference Range

Interpretive report provided.

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Specimen Requirements

Collection Onsite

Collect specimen in a lavender top tube. Send intact specimen to the lab within 24 hours. Include the patient's family history, pedigree, and ethnicity on the test requisition. Obtaining informed consent from the patient prior to genetic testing is strongly recommended. If desired, a UMHS Request and Consent for Genetic Testing form can be obtained by contacting the MMGL Molecular Genetics Laboratory at 615-2429 during business hours Monday - Friday or online at https://mlabs.umich.edu/sites/default/files/2020-01/file/pci-mmgl_infor….

Collection Offsite

Collect specimen in a lavender top tube. Send intact specimen within 24 hours if stored at room temperature or within 5 days if stored refrigerated. Include the patient's family history, pedigree, and ethnicity on the test requisition. Obtaining informed consent from the patient prior to genetic testing is strongly recommended. If desired, a UMHS Request and Consent for Genetic Testing form can be obtained from the MMGL Molecular Genetics Laboratory by contacting the MLabs Client Services Center at 800-862-7284 or online at https://mlabs.umich.edu/sites/default/files/2020-01/file/pci-mmgl_infor….

Lavender Top Tube
Normal Volume
5 - 10 mL EDTA whole blood
Minimum Volume
2 mL EDTA whole blood

Billing Information

CPT Code
81402
Pro Fee Code
 
LOINC
 

Have More Questions?

Explore our helpful billing resources:

Our High Standard

Quality that sets us apart

As the reference laboratory division of Michigan Medicine's Department of Pathology, MLabs shares the institution's commitment to applying established quality principles to clinical laboratory testing. Like other large organizations in complex, consequential fields, we rely on an established approach to monitor quality throughout the testing process.